Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma.

Van Arsdale AR, Arend RC, Cossio MJ, Erickson BK, Wang Y, Doo DW, Leath CA, Goldberg GL, Huang GS.

Cancer Med. 2018 Mar;7(3):616-625. doi: 10.1002/cam4.1335. Epub 2018 Feb 18.

2.

Malignant Endometrial Polyps in Uterine Serous Carcinoma: The Prognostic Value of Polyp Size and Lymphovascular Invasion.

Ouyang C, Frimer M, Hou LY, Wang Y, Goldberg GL, Hou JY.

Int J Gynecol Cancer. 2018 Mar;28(3):524-528. doi: 10.1097/IGC.0000000000001213.

PMID:
29420362
3.

Female Sex Hormone Receptor Profiling in Uterine Adenosarcomas.

Marcus JZ, Klobocista M, Karabakhtsian RG, Prossnitz E, Goldberg GL, Huang GS.

Int J Gynecol Cancer. 2018 Mar;28(3):500-504. doi: 10.1097/IGC.0000000000001183.

PMID:
29303935
4.

The gynecologic oncology fellowship interview process: Challenges and potential areas for improvement.

Gressel GM, Van Arsdale A, Dioun SM, Goldberg GL, Nevadunsky NS.

Gynecol Oncol Rep. 2017 Apr 7;20:115-120. doi: 10.1016/j.gore.2017.04.003. eCollection 2017 May.

5.

Uterine sarcoma with ambiguous histomorphology: A case report.

Miller EM, Fu Y, Vera RB, Goldberg GL, Karabakhtsian RG.

Gynecol Oncol Rep. 2017 Feb 16;20:30-33. doi: 10.1016/j.gore.2017.02.006. eCollection 2017 May.

6.

Physical activity-related differences in body mass index and patient-reported quality of life in socioculturally diverse endometrial cancer survivors.

Rossi A, Garber CE, Kaur G, Xue X, Goldberg GL, Nevadunsky NS.

Support Care Cancer. 2017 Jul;25(7):2169-2177. doi: 10.1007/s00520-017-3622-y. Epub 2017 Feb 16.

PMID:
28210862
7.

Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis.

Campbell IK, Leong D, Edwards KM, Rayzman V, Ng M, Goldberg GL, Wilson NJ, Scalzo-Inguanti K, Mackenzie-Kludas C, Lawlor KE, Wicks IP, Brown LE, Baz Morelli A, Panousis C, Wilson MJ, Nash AD, McKenzie BS, Andrews AE.

J Immunol. 2016 Dec 1;197(11):4392-4402. Epub 2016 Nov 2.

8.

Feasibility of a physical activity intervention for obese, socioculturally diverse endometrial cancer survivors.

Rossi A, Garber CE, Ortiz M, Shankar V, Goldberg GL, Nevadunsky NS.

Gynecol Oncol. 2016 Aug;142(2):304-10. doi: 10.1016/j.ygyno.2016.05.034. Epub 2016 Jun 4.

PMID:
27246303
9.

RNA-seq Identification of RACGAP1 as a Metastatic Driver in Uterine Carcinosarcoma.

Mi S, Lin M, Brouwer-Visser J, Heim J, Smotkin D, Hebert T, Gunter MJ, Goldberg GL, Zheng D, Huang GS.

Clin Cancer Res. 2016 Sep 15;22(18):4676-86. doi: 10.1158/1078-0432.CCR-15-2116. Epub 2016 Apr 27.

10.

Delayed Presentation of Vaginal Cuff Dehiscence after Robotic Hysterectomy for Gynecologic Cancer: A Case Series and Review of the Literature.

Escobar PA, Gressel GM, Goldberg GL, Kuo DY.

Case Rep Obstet Gynecol. 2016;2016:5296536. doi: 10.1155/2016/5296536. Epub 2016 Mar 27.

11.

Germline mutations of the DNA repair pathways in uterine serous carcinoma.

Frimer M, Levano KS, Rodriguez-Gabin A, Wang Y, Goldberg GL, Horwitz SB, Hou JY.

Gynecol Oncol. 2016 Apr;141(1):101-7. doi: 10.1016/j.ygyno.2015.12.034.

PMID:
27016235
12.

Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma.

Hou JY, Rodriguez-Gabin A, Samaraweera L, Hazan R, Goldberg GL, Horwitz SB, McDaid HM.

PLoS One. 2016 Mar 11;11(3):e0151750. doi: 10.1371/journal.pone.0151750. eCollection 2016. No abstract available.

13.

Prevalence and factors associated with cognitive deficit in women with gynecologic malignancies.

Van Arsdale A, Rosenbaum D, Kaur G, Pinto P, Kuo DY, Barrera R, Goldberg GL, Nevadunsky NS.

Gynecol Oncol. 2016 May;141(2):323-328. doi: 10.1016/j.ygyno.2016.03.001. Epub 2016 Mar 14.

PMID:
26946094
14.

G-CSF and Neutrophils Are Nonredundant Mediators of Murine Experimental Autoimmune Uveoretinitis.

Goldberg GL, Cornish AL, Murphy J, Pang ES, Lim LL, Campbell IK, Scalzo-Inguanti K, Chen X, McMenamin PG, Maraskovsky E, McKenzie BS, Wicks IP.

Am J Pathol. 2016 Jan;186(1):172-84. doi: 10.1016/j.ajpath.2015.09.008.

PMID:
26718978
15.

Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer.

Phaeton R, Jiang Z, Revskaya E, Fisher DR, Goldberg GL, Dadachova E.

Cancer Med. 2016 Jan;5(1):9-16. doi: 10.1002/cam4.562. Epub 2015 Dec 2.

16.

Association Between Statin Use and Endometrial Cancer Survival.

Nevadunsky NS, Van Arsdale A, Strickler HD, Spoozak LA, Moadel A, Kaur G, Girda E, Goldberg GL, Einstein MH.

Obstet Gynecol. 2015 Jul;126(1):144-50. doi: 10.1097/AOG.0000000000000926.

PMID:
26241267
17.

Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer.

Phaëton R, Gutierrez J, Jiang Z, Karabakhtsian RG, Albanese J, Sunkara J, Fisher DR, Goldberg GL, Dadachova E.

Immunotherapy. 2015;7(6):631-40. doi: 10.2217/imt.15.18. Epub 2015 Jun 22.

18.

HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study.

Frimer M, Sun C, McAndrew T, Smith B, Harari A, Chen Z, Mirabello L, Wentzensen N, Goldberg GL, Rodriguez AC, Schiffman M, Burk RD.

Gynecol Oncol. 2015 Jul;138(1):94-100. doi: 10.1016/j.ygyno.2015.05.001. Epub 2015 May 19.

19.

TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.

Seagle BL, Yang CP, Eng KH, Dandapani M, Odunsi-Akanji O, Goldberg GL, Odunsi K, Horwitz SB, Shahabi S.

Gynecol Oncol. 2015 Jul;138(1):159-64. doi: 10.1016/j.ygyno.2015.04.039. Epub 2015 May 6.

20.

Enhanced hematopoietic stem cell function mediates immune regeneration following sex steroid blockade.

Khong DM, Dudakov JA, Hammett MV, Jurblum MI, Khong SM, Goldberg GL, Ueno T, Spyroglou L, Young LF, van den Brink MR, Boyd RL, Chidgey AP.

Stem Cell Reports. 2015 Mar 10;4(3):445-58. doi: 10.1016/j.stemcr.2015.01.018. Epub 2015 Feb 26.

21.

In vivo multi-modal imaging of experimental autoimmune uveoretinitis in transgenic reporter mice reveals the dynamic nature of inflammatory changes during disease progression.

Chen X, Kezic JM, Forrester JV, Goldberg GL, Wicks IP, Bernard CC, McMenamin PG.

J Neuroinflammation. 2015 Jan 27;12:17. doi: 10.1186/s12974-015-0235-6.

22.

Simultaneous endometrial aspiration and sonohysterography for the evaluation of endometrial pathology in women aged 50 years and older.

Rotenberg O, Renz M, Reimers L, Doulaveris G, Gebb J, Goldberg GL, Dar P.

Obstet Gynecol. 2015 Feb;125(2):414-23. doi: 10.1097/AOG.0000000000000631.

PMID:
25568988
23.

Vulvar fibromatosis: a clinical enigma.

Conroy EM, Frimer M, Karabakhtsian RG, Gorlick R, Goldberg GL.

J Pediatr Hematol Oncol. 2015 Jan;37(1):63-7. doi: 10.1097/MPH.0000000000000261.

PMID:
25238226
24.

Image-guided drainage versus antibiotic-only treatment of pelvic abscesses: short-term and long-term outcomes.

To J, Aldape D, Frost A, Goldberg GL, Levie M, Chudnoff S.

Fertil Steril. 2014 Oct;102(4):1155-9. doi: 10.1016/j.fertnstert.2014.06.025. Epub 2014 Jul 23.

PMID:
25064405
25.

Obesity and age at diagnosis of endometrial cancer.

Nevadunsky NS, Van Arsdale A, Strickler HD, Moadel A, Kaur G, Levitt J, Girda E, Goldfinger M, Goldberg GL, Einstein MH.

Obstet Gynecol. 2014 Aug;124(2 Pt 1):300-6. doi: 10.1097/AOG.0000000000000381.

PMID:
25004350
26.

Role of elevated cancer antigen 19-9 in women with mature cystic teratoma.

Frimer M, Seagle BL, Chudnoff S, Goldberg GL, Shahabi S.

Reprod Sci. 2014 Oct;21(10):1307-11. doi: 10.1177/1933719114525274. Epub 2014 Feb 27.

PMID:
24577158
27.

Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo.

Agoni L, Basu I, Gupta S, Alfieri A, Gambino A, Goldberg GL, Reddy EP, Guha C.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1180-7. doi: 10.1016/j.ijrobp.2013.12.051. Epub 2014 Feb 11.

28.

Metformin use and endometrial cancer survival.

Nevadunsky NS, Van Arsdale A, Strickler HD, Moadel A, Kaur G, Frimer M, Conroy E, Goldberg GL, Einstein MH.

Gynecol Oncol. 2014 Jan;132(1):236-40. doi: 10.1016/j.ygyno.2013.10.026. Epub 2013 Nov 2.

29.

The role and timing of palliative medicine consultation for women with gynecologic malignancies: association with end of life interventions and direct hospital costs.

Nevadunsky NS, Gordon S, Spoozak L, Van Arsdale A, Hou Y, Klobocista M, Eti S, Rapkin B, Goldberg GL.

Gynecol Oncol. 2014 Jan;132(1):3-7. doi: 10.1016/j.ygyno.2013.10.025. Epub 2013 Oct 29.

30.

A clinical and pathologic comparison between stage-matched endometrial intraepithelial carcinoma and uterine serous carcinoma: is there a difference?

Hou JY, McAndrew TC, Goldberg GL, Whitney K, Shahabi S.

Reprod Sci. 2014 Apr;21(4):532-7. doi: 10.1177/1933719113503414. Epub 2013 Sep 10.

31.

Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010.

Hou JY, Aparo S, Ghalib M, Chaudhary I, Shah U, Swami U, Einstein M, Goldberg GL, Mani S, Goel S.

Gynecol Oncol. 2013 Oct;131(1):163-8. doi: 10.1016/j.ygyno.2013.07.089. Epub 2013 Jul 19.

PMID:
23877015
32.

Response to microtubule-interacting agents in primary epithelial ovarian cancer cells.

Pellicciotta I, Yang CP, Venditti CA, Goldberg GL, Shahabi S.

Cancer Cell Int. 2013 Apr 10;13(1):33. doi: 10.1186/1475-2867-13-33.

33.

End-of-life care of women with gynecologic malignancies: a pilot study.

Nevadunsky NS, Spoozak L, Gordon S, Rivera E, Harris K, Goldberg GL.

Int J Gynecol Cancer. 2013 Mar;23(3):546-52. doi: 10.1097/IGC.0b013e3182842efa.

34.

Exploiting MEK inhibitor-mediated activation of ERα for therapeutic intervention in ER-positive ovarian carcinoma.

Hou JY, Rodriguez-Gabin A, Samaraweera L, Hazan R, Goldberg GL, Horwitz SB, McDaid HM.

PLoS One. 2013;8(2):e54103. doi: 10.1371/journal.pone.0054103. Epub 2013 Feb 4. Erratum in: PLoS One. 2016;11(3):e0151750. Samaweera, Leleesha [corrected to Samaraweera, Leleesha].

35.

Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein.

Harris M, Wang XG, Jiang Z, Phaeton R, Koba W, Goldberg GL, Casadevall A, Dadachova E.

Br J Cancer. 2013 Mar 5;108(4):859-65. doi: 10.1038/bjc.2013.43. Epub 2013 Feb 5.

36.

Pulmonary fibrosis after pegylated liposomal Doxorubicin in a patient with uterine papillary serous carcinoma.

Nevadunsky NS, Mbagwu C, Mizrahi N, Burton E, Goldberg GL.

J Clin Oncol. 2013 Apr 1;31(10):e167-9. doi: 10.1200/JCO.2012.44.5767. Epub 2013 Jan 28. No abstract available.

37.

Flow cytometric analysis of STAT phosphorylation.

Murphy J, Goldberg GL.

Methods Mol Biol. 2013;967:161-5. doi: 10.1007/978-1-62703-242-1_11.

PMID:
23296728
38.

The clinical relevance of rising CA-125 levels within the normal range in patients with uterine papillary serous cancer.

Frimer M, Hou JY, McAndrew TC, Goldberg GL, Shahabi S.

Reprod Sci. 2013 Apr;20(4):449-55. doi: 10.1177/1933719112459218. Epub 2012 Sep 20.

39.

Histopathologic differences account for racial disparity in uterine cancer survival.

Smotkin D, Nevadunsky NS, Harris K, Einstein MH, Yu Y, Goldberg GL.

Gynecol Oncol. 2012 Dec;127(3):616-9. doi: 10.1016/j.ygyno.2012.08.025. Epub 2012 Aug 29.

40.

Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer.

Jenq RR, Curran MA, Goldberg GL, Liu C, Allison JP, van den Brink MR.

PLoS One. 2012;7(4):e35222. doi: 10.1371/journal.pone.0035222. Epub 2012 Apr 6.

41.

Clinical utility of chromogranin A and octreotide in large cell neuro endocrine carcinoma of the uterine corpus.

Shahabi S, Pellicciotta I, Hou J, Graceffa S, Huang GS, Samuelson RN, Goldberg GL.

Rare Tumors. 2011 Oct 21;3(4):e41. doi: 10.4081/rt.2011.e41. Epub 2011 Oct 11.

42.

Destructive T10 vertebral lesion leads to diagnosis of metastatic ovarian cancer.

Callery RJ, Burton E, Sharan A, Yassari R, Goldberg GL.

Gynecol Oncol Case Rep. 2012 Nov 1;4:1-3. doi: 10.1016/j.gynor.2012.10.007. eCollection 2012.

43.

Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma.

Einstein MH, Klobocista M, Hou JY, Lee S, Mutyala S, Mehta K, Reimers LL, Kuo DY, Huang GS, Goldberg GL.

Gynecol Oncol. 2012 Jan;124(1):26-30. doi: 10.1016/j.ygyno.2011.10.008. Epub 2011 Nov 3.

44.

Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma.

Einstein MH, Frimer M, Kuo DY, Reimers LL, Mehta K, Mutyala S, Huang GS, Hou JY, Goldberg GL.

Gynecol Oncol. 2012 Jan;124(1):21-5. doi: 10.1016/j.ygyno.2011.10.007. Epub 2011 Oct 27.

45.

Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer.

Burton ER, Gaffar A, Lee SJ, Adeshuko F, Whitney KD, Chung JY, Hewitt SM, Huang GS, Goldberg GL, Libutti SK, Kwon M.

Mol Cancer Res. 2011 Aug;9(8):1126-38. doi: 10.1158/1541-7786.MCR-11-0162. Epub 2011 Jun 21.

46.

Epothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells.

Pellicciotta I, Yang CP, Goldberg GL, Shahabi S.

Gynecol Oncol. 2011 Sep;122(3):625-31. doi: 10.1016/j.ygyno.2011.05.007. Epub 2011 May 28.

PMID:
21621254
47.

Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.

Hanash AM, Kappel LW, Yim NL, Nejat RA, Goldberg GL, Smith OM, Rao UK, Dykstra L, Na IK, Holland AM, Dudakov JA, Liu C, Murphy GF, Leonard WJ, Heller G, van den Brink MR.

Blood. 2011 Jul 14;118(2):446-55. doi: 10.1182/blood-2010-07-294785. Epub 2011 May 19.

48.

Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma.

Gupta D, Gunter MJ, Yang K, Lee S, Zuckerwise L, Chen LM, Goldberg GL, Huang GS.

Int J Gynecol Cancer. 2011 Apr;21(3):529-34. doi: 10.1097/IGC.0b013e31821091b5.

PMID:
21436701
49.

Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.

Harris M, Wang XG, Jiang Z, Goldberg GL, Casadevall A, Dadachova E.

Head Neck Oncol. 2011 Feb 12;3(1):9. doi: 10.1186/1758-3284-3-9.

50.

Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): a pooled analysis.

Hou J, Goldberg GL, Qualls CR, Kuo DY, Forman A, Smith HO.

Gynecol Oncol. 2011 Apr;121(1):135-42. doi: 10.1016/j.ygyno.2010.11.036. Epub 2010 Dec 30.

PMID:
21193227

Supplemental Content

Loading ...
Support Center